News
You may sort news by title, date or business need. If you wish to detail your search, please select the categories from the left. If you wish to see events at which Quintiles is scheduled to participate, please select the events link from the top.
- Sort by:
- Most Recent
- Title
-
QUINTILES VIRTUAL CLINICAL RESEARCH COMMUNITY REACHES 2 MILLION
December 22, 2009 – Quintiles announced it has developed a community of more than 2 million clinically profiled patients who have opted in to volunteer or provide insights and guidance to advance clinical research through its proprietary Web site iGuard.org.
-
QUINTILES HONORED AS CRO OF THE YEAR AT 2009 SCRIP AWARD
Research Triangle Park, NC, December 14, 2009 – Quintiles has been named CRO of the Year by the prestigious SCRIP Awards. The panel of judges highlighted Quintiles’ breadth of services and its outstanding relationships with clients.
-
QUINTILES OPENS EXPANDED ASIA-PACIFIC HEADQUARTERS IN SINGAPORE
November 6, 2009 - To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles announced the official grand opening of its expanded Asia-Pacific regional headquarters facility in Singapore's Science Park I.
-
QUINTILES’ BILL DEAM NAMED TO CIO HALL OF FAME
November 2, 2009 - Quintiles Executive Vice President and Chief Information Officer (CIO) William “Bill” Deam has been named to the “CIO Hall of Fame” which selects honorees for their leadership in the CIO community and contributions to the advancement of the profession.
-
QUINTILES ANNOUNCES CLINICAL PHARMACOLOGY ALLIANCE WITH ASTRAZENECA
November 2, 2009 - Quintiles has entered into in an industry-leading clinical pharmacology alliance with AstraZeneca to deliver AstraZeneca’s clinical pharmacology studies across multiple therapy areas and around the globe.
-
QUINTILES ANNOUNCES STRATEGIC ALLIANCE TO ADVANCE EISAI’S ONCOLOGY PIPELINE
October 30, 2009 - Quintiles announced a strategic alliance with leading global pharmaceutical company Eisai Co. Ltd. (Tokyo, Japan) to develop six potential oncology products in Eisai’s R&D pipeline.
-
QUINTILES CONSULTING STRENGTHENS REGULATORY & QUALITY CAPABILITIES
October 29, 2009 - Quintiles Consulting today announced three key appointments in its US Regulatory and Quality consulting practice. These new appointments expand Quintiles’ experience in regulatory compliance and quality system development.
-
QUINTILES PARTNERS WITH FOUNDATION TRUST & UNIVERSITY TO IMPROVE PATIENT CARE AND DRIVE EFFICIENCY IN CLINICAL RESEARCH
October 26, 2009 - A significant step in driving innovation, improving patient care and increasing efficiency in early stage clinical research was taken today with the announcement that two of the UK’s leading institutions - Guy’s and St Thomas’ NHS Foundation Trust and King’s College London - have signed a collaborative agreement with Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide.
-
QUINTILES CONSULTING EXPLORES IMPACT OF COMPARATIVE EFFECTIVENESS RESEARCH ON DRUG DEVELOPMENT
October 21, 2009 – In a new report released today, John Doyle, Vice President and Practice Leader for Quintiles Consulting, and an expert on pharmaceutical market access, explores the complex issue of comparative effectiveness research (CER) and its strategic importance in successful and efficient biopharmaceutical development.
-
QUINTILES AND CERNER WORK TOGETHER TO IMPROVE EFFICIENCY OF LATE PHASE RESEARCH STUDIES
October 1, 2009 – Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting
